321 Results

People

  1. Giralt
    Giralt
  2. Perales
    Perales
  3. Devlin
    Devlin
  4. Shah
    Shah
  5. Sauter
    Sauter
  6. Palomba
    Palomba
  7. Brentjens
    Brentjens
  8. Halton
    Halton
  9. Park
    Park
  10. Moskowitz
    Moskowitz

Groups

  1. Advanced Practice Providers (321)
  2. Center for Hematologic Malignancies (321)
  3. Department of Medicine (297)
  4. Hematologic Malignancies, Division of (285)
  5. Nursing (263)
  6. Survivorship Research (181)
  7. Bone Marrow Transplant (172)
  8. GSK Faculty (139)
  9. Epidemiology and Biostatistics (128)
  10. Biostatistics Service (115)
  1. "Center for Hematologic Malignancies"
  2. "Advanced Practice Providers"
Formats
  1. Meeting Abstract (213)
  2. Journal Article (98)
  3. Research Letter (7)
  4. Book Section (1)
  5. Correspondence (1)
  6. Review (1)
Groups
  1. Advanced Practice Providers (321)
  2. Center for Hematologic Malignancies (321)
  3. Department of Medicine (297)
  4. Hematologic Malignancies, Division of (285)
  5. Nursing (263)
  6. Survivorship Research (181)

More Groups

People
  1. Sergio Giralt (94)
  2. Miguel-Angel Perales (73)
  3. Gunjan Shah (64)
  4. Sean Devlin (64)
  5. Craig Sauter (62)
  6. Maria Palomba (58)

More People

Years
  1. 2024 (2)
  2. 2023 (17)
  3. 2022 (22)
  4. 2021 (36)
  5. 2020 (26)
  6. 2019 (40)

More Years

Publications
  1. Blood (100)
  2. Biology of Blood and Marrow Transplantation (51)
  3. Journal of Clinical Oncology (29)
  4. Bone Marrow Transplantation (11)
  5. Hematological Oncology (10)
  6. Neuro-Oncology (9)

More Publications

Publishers
  1. American Society of Hematology (106)
  2. Elsevier Inc. (66)
  3. American Society of Clinical Oncology (32)
  4. Nature Publishing Group (19)
  5. Wiley Blackwell (15)
  6. Oxford University Press (14)

More Publishers

Results (321)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • T-cell depleted allogeneic hematopoietic stem cell transplant for the treatment of Fanconi anemia and MDS/AML
    Journal Article

    Satty, A. M.; Klein, E.; Mauguen, A.; Kunvarjee, B.; Boelens, J. J.; Cancio, M.; Curran, K. J.; Kernan, N. A.; Prockop, S. E.; Scaradavou, A.; more...
    Bone Marrow Transplantation (2024)

    Fulltext@MSK | Save
  • Quantifying the expanding landscape of clinical actionability for patients with cancer
    Journal Article

    Suehnholz, S. P.; Nissan, M. H.; Zhang, H.; Kundra, R.; Nandakumar, S.; Lu, C.; Carrero, S.; Dhaneshwar, A.; Fernandez, N.; Xu, B. W.; more...
    Cancer Discovery (2024)

    Fulltext@MSK | Save
  • Reduced dose brentuximab vedotin for mycosis fungoides appears to prolong response duration by balancing efficacy and tolerability
    Meeting Abstract

    Munayirji, B.; Khan, N.; Myskowski, P.; Geller, S.; Noor, S.; Kheterpal, M. K.; Davey, T.; Hancock, H.; Perez, L.; Miller, T.; more...
    Blood (2023)

    Fulltext@MSK | Save
  • A multicenter phase 2 trial of zanubrutinib, obinutuzumab, and venetoclax (BOVen) in patients with treatment-naïve, TP53-mutant mantle cell lymphoma
    Meeting Abstract

    Kumar, A.; Soumerai, J.; Abramson, J. S.; Barnes, J. A.; Caron, P.; Chabowska, M.; Devlin, M.; Dogan, A.; Falchi, L.; Garcia, R. N.; more...
    Blood (2023)

    Fulltext@MSK | Save
  • A phase II trial of prophylactic anakinra to prevent neurotoxicity in patients receiving anti-CD19 CAR T-cell therapy for relapsed or refractory lymphoma: Final results from cohort 2
    Meeting Abstract

    Nath, K.; Devlin, S. M.; Sauter, C. S.; Palomba, M. L.; Shah, G. L.; Dahi, P. B.; Lin, R. J.; Scordo, M.; Perales, M. A.; Leslie, L. A.; more...
    Blood (2023)

    Fulltext@MSK | Save
  • Ruxolitinib promotes clinical responses in large granular lymphocytic leukemia via suppression of JAK/STAT-dependent inflammatory cascades
    Meeting Abstract

    Moskowitz, A.; Rahman, J.; Ganesan, N.; Hannigan, K.; Ksanznak, K.; Bitton, H.; Lin, Y. H.; Davey, T.; Hancock, H.; Perez, L.; more...
    Blood (2023)

    Fulltext@MSK | Save
  • Low target antigen expression mediates resistance to BCMA CAR T cell therapy
    Meeting Abstract

    Perica, K.; Nataraj, S.; Sjojstrand, M. L.; Nagel, K.; Pavkovic, E.; Payson, E.; Cuenca, A.; Patel, A.; Chung, D.; Mailankody, S.; more...
    Blood (2023)

    Fulltext@MSK | Save
  • Distinct patterns of CD4+and CD8+ T-cell clonal expansion enable broad clinical responses to pembrolizumab + GVD in patients with relapsed Hodgkin lymphoma
    Meeting Abstract

    Wills, B.; Rahman, J.; Ganesan, N.; Shah, G. L.; Noy, A.; Schoder, H.; Yahalom, J.; Kumar, A.; Falchi, L.; Hamlin, P. A.; more...
    Blood (2023)

    Fulltext@MSK | Save
  • Utility of routine pulmonary function test after autologous hematopoietic cell transplantation in lymphoma
    Journal Article

    Dahi, P. B.; Kenny, S.; Flynn, J.; Devlin, S. M.; Ruiz, J. D.; Chinapen, S. A.; Lahoud, O. B.; Matasar, M. J.; Moskowitz, C. H.; Perales, M. A.; more...
    Leukemia and Lymphoma (2023)

    Fulltext@MSK | Save
  • Ipilimumab after CD34-selected allogeneic stem cell transplantation (Allo HCT) for patients with relapsed/refractory multiple myeloma (RRMM)
    Meeting Abstract

    Ghosh, A.; Nagel, K.; Hosszu, K.; Datta, A.; Thompson, C.; Levia, K.; Kamrowski, A.; McAvoy, D.; Chung, D.; Landau, H.; more...
    Clinical Lymphoma, Myeloma and Leukemia (2023)

    Fulltext@MSK | Save